VRNOD (Verano Holdings) ROCE %: 1.53% (As of Mar. 2026)

What is Verano Holdings ROCE %?

Verano Holdings VRNOD +0.19% 65 ROCE % is 1.53% as of Mar. 2026. GuruFocus rates VRNOD with a GF Score™ of 65/100 and a GF Value™ of $9.39 (Possible Value Trap). The stock has 7 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Verano Holdings's annualized ROCE % for the quarter that ended in Mar. 2026 was 1.53%.

Verano Holdings (OTCPK:VRNOD) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Verano Holdings ROCE % Related Terms

Verano Holdings ROCE % Historical Data

* Premium members only.

The historical data trend for Verano Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Verano Holdings ROCE % Chart

Verano Holdings Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROCE %

Get a 7-Day Free Trial

7.05

-5.58

4.47

-13.26

-6.64

Verano Holdings Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															4.32	6.72	-0.49	-37.85	1.53

65GF Score

Verano Holdings Corp VRNOD

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Verano Holdings ROCE % Calculation

Verano Holdings's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	-112.641	/	( ( (1994.1 - 203.112)	+	(1741.594 - 140.261) )	/ 2 )
	=	-112.641	/	( (1790.988	+	1601.333)	/ 2 )
	=	-112.641	/	1696.1605
	=	-6.64 %

Verano Holdings's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	24.448	/	( ( (1741.594 - 140.261)	+	(1708.348 - 118.911) )	/ 2 )
	=	24.448	/	( ( 1601.333	+	1589.437 )	/ 2 )
	=	24.448	/	1595.385
	=	1.53 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of 1.53% mean?

Verano Holdings (VRNOD) has a ROCE % of 1.53% as of Mar. 2026.

Is Verano Holdings' ROCE % too high?

Verano Holdings' current ROCE % is 1.53%. The Drug Manufacturers industry median ROCE % is 7.00. Verano Holdings' value of 1.53% is 78.1% below this industry median. Overall, Verano Holdings has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Verano Holdings' ROCE % compare to ZTS?

Verano Holdings' ROCE % of 1.53% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.00. Verano Holdings' value of 1.53% is 78.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Drug Manufacturers company?

The median ROCE % among Drug Manufacturers companies is 7.00, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Verano Holdings's current ROCE % of 1.53% is 78.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Verano Holdings's current ROCE % is 1.53%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Verano Holdings stock overvalued right now?

Based on GuruFocus' analysis, Verano Holdings (VRNOD) is currently considered Possible Value Trap. The stock's GF Value™ is $9.39, compared to a current price of $5.31 — trading 43.5% below its estimated fair value. The current ROCE % is 1.53% and 78.1% below the Drug Manufacturers industry median of 7.00. Verano Holdings' overall GF Score™ is 65/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Verano Holdings (VRNOD), the current ROCE % is 1.53% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Verano Holdings (VRNOD) Overvalued in 2026?

Based on GuruFocus' analysis, Verano Holdings stock appears to be undervalued. The current stock price of $5.31 is trading 43.5% below its estimated GF Value™ of $9.39. GuruFocus considers Verano Holdings to be Possible Value Trap.

Key valuation signals for VRNOD:

ROCE %: 1.53%
GF Value™: $9.39 vs. price of $5.31 (43.5% below fair value)
GF Score™: 65/100 with 7 warning signs
Industry Position: 78.1% below the Drug Manufacturers median

No single metric tells the full story. See the VRNOD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Verano Holdings Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies TSX:WEED XCNQ:CL TSX:CPH TSX:GUD XCNQ:VREO TSX:TSND TSX:ACB TSX:DHT.U TSX:OGI TSX:XLY XTER:MRK TSE:4502 XSWX:GALD SHSE:600276 NSE:SUNPHARMA XTAE:TEVA LSE:HLN XSWX:SDZ ZTS HKSE:03692

Other Exchanges H7P0:Germany VRNO:Canada

Address 224 West Hill Street, Suite 400, Chicago, IL, USA, 60610

Website https://www.verano.com

Verano Holdings Corp is a vertically integrated, multi-state cannabis operator in the United States. The company operates through cultivation (wholesale) and retail segments. Its consumer brands include Encore, Avexia, MUV, Savvy, BITS, and Verano, while its retail dispensaries operate under brands such as Zen Leaf and MUV. The company derives the majority of its revenue from the retail segment.

65GF Score

Get the complete analysis for VRNOD

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.31

Price

$9.39

GF Value

View VRNOD Analysis

See ROCE % data for all stocks →